源自类风湿关节炎患者的抗肽酰基精氨酸脱亚胺酶4自身抗体通过激活单核细胞并加重炎性关节炎发挥致病作用
研究探讨抗PAD4抗体在类风湿关节炎中的致病机制,使用胶原诱导性关节炎小鼠模型和人类单核细胞体外培养,发现抗PAD4抗体治疗加重CIA小鼠疾病严重度,优先结合人和小鼠单核细胞并诱导促炎趋化因子产生,IL-17A、TNFα和IFNγ协同诱导人类成纤维样滑膜细胞促炎表型。
要点
- 抗PAD4抗体治疗加重CIA小鼠关节炎严重度,伴关节损伤、髓系细胞浸润和滑膜成纤维细胞活化增加。
- 抗PAD4抗体优先结合人和小鼠单核细胞,体外诱导人单核细胞产生促炎趋化因子。
- CIA模型中抗PAD4抗体增强的IL-17A、TNFα和IFNγ协同诱导人成纤维样滑膜细胞促炎表型。
核心结论
- 研究结果提示抗PAD4抗体结合单核细胞触发炎症级联反应,促进免疫细胞向关节募集和T细胞活化,最终导致滑膜成纤维细胞活化和更严重的关节炎。
研究设计与样本
- 使用源自类风湿关节炎患者的抗PAD4单克隆抗体,在胶原诱导性关节炎小鼠模型和人类单核细胞体外培养中进行研究。
- 使用小鼠膝关节细胞和人外周血单个核细胞鉴定抗PAD4抗体的细胞靶点。
- 使用人成纤维样滑膜细胞体外培养和源自类风湿关节炎患者的单细胞RNA测序数据集评估PAD4基因和蛋白表达。
主要发现
- 抗PAD4抗体治疗加重CIA小鼠模型疾病严重度,伴关节损伤增加、髓系细胞浸润和滑膜成纤维细胞活化。
- 接受抗PAD4抗体的关节炎小鼠中产生IL-17A、TNFα和IFNγ的T细胞比例增加。
- 抗PAD4抗体优先结合人和小鼠单核细胞,体外诱导人单核细胞产生促炎趋化因子。
- CIA模型中抗PAD4抗体增强的T细胞细胞因子(IL-17A、TNFα和IFNγ)协同诱导人成纤维样滑膜细胞促炎表型。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Autoantibodies targeting peptidylarginine deiminase 4 (PAD4), an enzyme involved in protein citrullination, are found in a subset of patients with rheumatoid arthritis (RA) with severe joint disease. However, the mechanisms by which anti-PAD4 antibodies participate in disease pathogenesis are incompletely defined. METHODS: We investigated the role of anti-PAD4 monoclonal antibodies derived from patients with RA using a collagen-induced arthritis (CIA) mouse model and human monocyte in vitro cultures. The cellular targets of anti-PAD4 antibodies were identified using mouse knee joint cells and human peripheral blood mononuclear cells. In addition, PAD4 gene and protein expression was assessed using human fibroblast-like synoviocyte in vitro cultures and a single-cell RNA sequencing data set obtained from patients with RA. RESULTS: We show that anti-PAD4 antibody treatment augmented disease severity in the CIA mouse model, with increased joint damage, myeloid cell infiltration, and synovial fibroblast activation. Arthritic mice administered with anti-PAD4 antibodies had an increased proportion of interleukin-17A (IL-17A), tumor necrosis factor α (TNFα), and interferon-γ (IFNγ)-producing T cells. Anti-PAD4 antibodies preferentially bound monocytes in both humans and mice, eliciting proinflammatory chemokine production by human monocytes in vitro. T cell cytokines enhanced by anti-PAD4 antibodies in the CIA model (ie, IL-17A, TNFα, and IFNγ) synergized to induce a proinflammatory phenotype in human fibroblast-like synoviocytes. CONCLUSION: Our findings suggest a model in which anti-PAD4 antibody binding to monocytes triggers an inflammatory cascade that promotes immune cell recruitment to the joint and T cell activation, culminating in synovial fibroblast activation and the development of more severe arthritis.
引用
- Won T, Naik P, Wood MK, et al. Anti-Peptidylarginine Deiminase 4 Autoantibodies Derived From Patients With Rheumatoid Arthritis Exert Pathogenic Effects by Activating Monocytes and Exacerbating Inflammatory Arthritis. Arthritis Rheumatol. 2025. PMID: 40176290. doi:10.1002/art.43168
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。